These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 854707)

  • 1. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
    Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
    Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
    Umeki S; Umeki Y
    Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.
    Arnesen H; Smith P
    Thromb Res; 1991 Feb; 61(3):311-4. PubMed ID: 1822957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 5. Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.
    Girolami A; Patrassi G; Fabris F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):283-93. PubMed ID: 69593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a lyophilized reference plasma to compare coagulation test procedures: Normotest, Simplastin-A and Thrombotest.
    Kahan J; Norén I
    Thromb Diath Haemorrh; 1975 Nov; 34(2):426-44. PubMed ID: 1198406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a modified calibration model for reliable conversion of thromboplastin times to international normalized ratios.
    Gogstad GO; Wadt J; Smith P; Brynildsrud T
    Thromb Haemost; 1986 Oct; 56(2):178-82. PubMed ID: 3810555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2.
    Takahashi H; Wada K; Satoh N; Takakuwa E; Furuta R; Yoshino N; Shibata A
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):435-9. PubMed ID: 8329570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepant INR values: a comparison between Manchester and Thrombotest reagents using capillary and venous samples.
    Morrison M; Caldwell A; McQuaker G; Fitzsimons EJ
    Clin Lab Haematol; 1989; 11(4):393-8. PubMed ID: 2605880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the dose of warfarin for therapeutic anticoagulation.
    Sharma NK; Routledge PA; Rawlins MD; Davies DM
    Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a recombinant thromboplastin with Thrombotest for oral anticoagulant control.
    Baele G; Fiers T; Leroux-Roels G
    Haemostasis; 1996; 26(1):11-5. PubMed ID: 8698273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statistical comparison between prothrombin time, Owren's thrombotest and cephalin time during the surveillance of anticoagulant therapy].
    Aznar J; Fernández Pavón A; Aznar JA
    Sangre (Barc); 1972; 17(2):187-92. PubMed ID: 5035457
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
    Girolami A; Patrassi G; Burul A
    Blut; 1976 Jul; 33(1):41-8. PubMed ID: 974273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio.
    Ignjatovic V; Barnes C; Newall F; Hamilton S; Burgess J; Monagle P
    Thromb Haemost; 2004 Oct; 92(4):734-7. PubMed ID: 15467903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.
    Girolami A; Brunetti A; Patrassi GM
    Am J Clin Pathol; 1977 Jan; 67(1):57-60. PubMed ID: 831455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting patients' warfarin requirements.
    Routledge PA; Davies DM; Bell SM; Cavanagh JS; Rawlins MD
    Lancet; 1977 Oct; 2(8043):854-5. PubMed ID: 72199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of prothrombin time and thrombotest and hepaplastin test for the control of oral anticoagulant therapy].
    Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
    Rinsho Byori; 1983 Feb; 31(2):210-4. PubMed ID: 6855001
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation.
    Jennings I; Luddington RJ; Baglin T
    J Clin Pathol; 1991 Nov; 44(11):950-3. PubMed ID: 1752987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the one-stage prothrombin time.
    Talstad I
    Haemostasis; 1985; 15(5):310-7. PubMed ID: 4076837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.